Inventor · disambiguated record
Jens Onken
Also filed as: ONKEN JENS
2 granted patents·9 pending applications·3 citations·filing 2006–2024
48Inventor score
Top patents by PatentIndex Score
11 records- 0178US9198871B2Delayed release pancreatin compositionsSHLIEOUT GEORGE·Filed 2006·Granted Dec 1, 2015·3 cites·32 claims
- 0268US2021353722A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2021·Application pending·0 cites
- 0366US2019247473A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2019·Application pending·0 cites
- 0466US2021060142A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2020·Application pending·0 cites
- 0566US2024148660A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2024·Application pending·0 cites
- 0661US2014065232A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2013·Application pending·0 cites
- 0758US2022183988A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 0856US11266607B2Process for the manufacture and use of pancreatin micropellet coresSHLIEOUT GEORGE·Filed 2006·Granted Mar 8, 2022·0 cites·101 claims
- 0956US2016263201A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2016·Application pending·0 cites
- 1055US2024226249A9Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2023·Application pending·0 cites
- 1155US2016095906A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jens Onken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →